Yaoyanshe (also known as Shanghai Mudi Biological Technology and 药研社) is an AI-based clinical research organization. It develops six health tech platforms: Trial.Link, 药研社APP, 健康秘书APP, MY-PMCP, MY-TDC, and MY-EDC. The company enables users to connect with drug enterprises, hospitals, researchers, industry practitioners, and patients as well as provides drug development, patient recruitment, patient-reported outcome, patient education, consulting, and other services.